Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals is developing innovative therapies and vaccines to improve population health.
Sector
Subsector
Keywords
Location
total rounds
total raised
Promentis Pharmaceuticals
Promentis Pharmaceuticals develops antipsychotic drugs to treat schizophrenia.
Sector
Subsector
Keywords
Location
total rounds
total raised
ATXA Therapeutics
ATXA is a clinical-stage pharmaceutical company that develops novel small molecule drugs to treat Pulmonary Arterial Hypertension.
Sector
Subsector
Keywords
Location
total rounds
total raised
Durata Therapeutics
Durata Therapeutics is a clinical development stage biopharmaceutical company.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds2
Number of Funding Rounds
Money Raised
Their latest funding was raised on 24.05.2013. Their latest round Private Equity
Co-Investors
Investors1
Number of lead investors
Number of investors
BlueSky Capital
BlueSky Capital is an Ontario-based private investment firm specializing in various industries.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders2
Michael Tymianski
Dr. Tymianski founded NoNO Inc. in 2003 to commercialize development technology stemming from his research laboratory. Dr. Tymianski has been the President and CEO of the Company since its inception, and has propelled its lead technologies from the discovery stage to ongoing late-stage pivotal clinical trials. While executing on the vision and strategic directions of the Company, Dr. Tymianski has assembled one of Canada’s most dynamic biotechnology discovery teams, ranging from drug and target validation, chemistry, preclinical IND-enabling research, and through to clinical operations culminating in to global clinical trials. He is also the Head of the Division of Neurosurgery at the University Health Network in Toronto and a Professor of Surgery and Physiology at the University of Toronto, providing the company with unique access to academic preclinical and clinical research teams. He is the Harold and Esther Halpern Chair in Neurosurgical Stroke Research and a Canada Research Chair (Tier 1) in Translational Stroke Research. Dr. Tymianski was invested into the Order of Canada in January 2018.
current job
organization founded
Michael Tymianski
Michael W. Salter
Dr. Salter is the co-founder of NoNO Inc. Together with the CEO and the Chief Technology and Administrative Officer, Dr. Salter directs the Company’s financial operations. As the Chief of Research at The Hospital for Sick Children Research Institute, he is an experienced researcher and administrator. Dr. Salter holds the Northbridge Chair in Pediatric Research, is a Professor of Physiology at the University of Toronto and is the former Director of the University of Toronto Centre for the Study of Pain.
current job
organization founded
Michael W. Salter
Employee Profiles3
Michael W. Salter
Co-founder & Vice President, Finance